Collaborative Filtering on a Family of Biological Targets
By Dumitru Erhan, Pierre-Jean L'Heureux, S. Yue, Yoshua Bengio. 2006
102 citations recorded by the source corpus.
Subfields: Artificial Intelligence, Molecular Biology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Artificial Intelligence
- Patrick F. Riley
- Laurent Jacob
- Jean-Philippe Vert
- Vijay S. Pande
- Horacio Emilio Pérez Sánchez
- Bharath Ramsundar
- Steven M. Kearnes
- Dale R. Webster
In Molecular Biology
- Jean-Philippe Vert
- Laurent Jacob
- David E. Konerding
- Bharath Ramsundar
- Vijay S. Pande
- Patrick F. Riley
- Steven M. Kearnes
- Dale R. Webster
Citations in the corpus
- Modeling Industrial ADMET Data with Multitask Networks (2016, background): “Previous attempts to quantify relatedness have focused on shared compounds or correlations between labels [Erhan et al., 2006; Ramsundar et al., 2015].”
- Massively Multitask Networks for Drug Discovery (2015, background): “Another closely related work proposed the use of collaborative filtering for virtual screening and employed both multitask networks and kernel-based methods (Erhan et al., 2006).”
- A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data (2012, methodology): “To overcome the shortcomings of these two approaches, several statistical models have been developed to predict the interactions, such as the binary classification models [36,37] and the supervised bipartite graph inference ones [38,39].”
- Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework (2010, unknown): “Contact: yoshihiro.yamanishi@ensmp.fr”
- Protein-ligand interaction prediction: an improved chemogenomics approach (2008, background): “The classical paradigm is to predict the modulators of a given ∗To whom correspondence should be addressed. target, considering each target independently from other proteins.”
- Accelerating Drugs Discovery with Deep Reinforcement Learning: An Early Approach (2018, methodology): “They have been also successfully applied in drug discovery [6, 12, 33], including application such as QSAR [32], genomics [1, 61], and VS [8, 58].”